Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Receivables - Net (2024 - 2025)

Historic Receivables - Net for Syndax Pharmaceuticals (SNDX) over the last 2 years, with Q3 2025 value amounting to $25.4 million.

  • Syndax Pharmaceuticals' Receivables - Net changed N/A to $25.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.4 million, marking a year-over-year change of. This contributed to the annual value of $7.6 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Syndax Pharmaceuticals' Receivables - Net stood at $25.4 million.
  • Over the past 5 years, Syndax Pharmaceuticals' Receivables - Net peaked at $25.4 million during Q3 2025, and registered a low of $7.6 million during Q4 2024.